<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ochs J</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>4183-4190</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12777740</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(8)</volume><pubmed_abstract>Similar to Pt&lt;sup>IV&lt;/sup> prodrugs, Au&lt;sup>III&lt;/sup> anticancer complexes are believed to undergo intracellular reduction, thereby gaining their activity from the resulting Au&lt;sup>I&lt;/sup> species. Unlike for Pt&lt;sup>IV&lt;/sup>, the underlying mechanism of this process remains poorly understood for Au&lt;sup>III&lt;/sup>. To elucidate this mechanism, we investigated the reaction of [Au(ppy)Cl&lt;sub>2&lt;/sub>], a model Au&lt;sup>III&lt;/sup> complex (ppy: phenylpyridine), with two biologically relevant reductants: lipoic acid (lpa) and &lt;i>N&lt;/i>-acetyl-l-cysteine-methyl ester (NAC-OMe). Our findings reveal that lpa transfers a hydride to the Au, while cysteine derivatives only bind to the metal. The Au-H complex, even visible in protic solvents by NMR spectroscopy, produced by lpa is essential for enabling a s</pubmed_abstract><journal>Chemical science</journal><pubmed_title>Identification of Au-hydrides as key intermediates in the reduction of Au(iii) prodrugs to active Au(i) species under protic conditions.</pubmed_title><pmcid>PMC12777740</pmcid><funding_grant_id>GRK 2341 “Microbial Substrate Conversion”</funding_grant_id><pubmed_authors>Metzler-Nolte N</pubmed_authors><pubmed_authors>Ochs J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of Au-hydrides as key intermediates in the reduction of Au(iii) prodrugs to active Au(i) species under protic conditions.</name><description>Similar to Pt&lt;sup>IV&lt;/sup> prodrugs, Au&lt;sup>III&lt;/sup> anticancer complexes are believed to undergo intracellular reduction, thereby gaining their activity from the resulting Au&lt;sup>I&lt;/sup> species. Unlike for Pt&lt;sup>IV&lt;/sup>, the underlying mechanism of this process remains poorly understood for Au&lt;sup>III&lt;/sup>. To elucidate this mechanism, we investigated the reaction of [Au(ppy)Cl&lt;sub>2&lt;/sub>], a model Au&lt;sup>III&lt;/sup> complex (ppy: phenylpyridine), with two biologically relevant reductants: lipoic acid (lpa) and &lt;i>N&lt;/i>-acetyl-l-cysteine-methyl ester (NAC-OMe). Our findings reveal that lpa transfers a hydride to the Au, while cysteine derivatives only bind to the metal. The Au-H complex, even visible in protic solvents by NMR spectroscopy, produced by lpa is essential for enabling a s</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T21:26:13.256Z</modification><creation>2026-07-10T03:16:03.167Z</creation></dates><accession>S-EPMC12777740</accession><cross_references><pubmed>41510013</pubmed><doi>10.1039/d5sc06212h</doi></cross_references></HashMap>